simplywall.st Balance sheet
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 168
- Sources here
- 19
- Companies here
- 16
Active search
168 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Technical Reactions to MOMO Trends in Macro Strategies
This article analyzes Hello Group Inc. (NASDAQ: MOMO) using AI models to provide technical reactions and trading strategies. It highlights a stable neutral reading in shorter horizons, potentially easing a long-term weak bias, and offers specific entry, target, and stop-loss points for position, momentum, …
Satellos Bioscience Inc. Stock 12‑Month Price Target Cut to $21.78, Implies 122% Upside
Satellos Bioscience Inc.'s average 12-month price target has been adjusted to $21.78, down from $22.04, according to estimates from 6 analysts. This new target suggests a potential upside of approximately 122% from the August 13 closing price. The consensus rating among 7 covering analysts …
Satellos Q2 loss widens to $11.7M, EPS misses estimates
Satellos Bioscience reported a Q2 2026 net loss of $11.7 million, or $0.56 per share, missing analyst estimates due to significantly increased R&D spending on its Phase 2 DMD clinical trials. Despite the widening loss, the company's cash reserves rose to $61.8 million, providing …
Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress
Satellos Bioscience Inc. announced its Q2 2026 financial results, reporting a strong cash position of $61.8 million and progress in its clinical trials for SAT-3247, a drug candidate for Duchenne muscular dystrophy (DMD). The company highlighted favorable safety data from the TRAILHEAD adult DMD …
Satellos reports stable strength in four-adult Duchenne study
Satellos reported its second quarter 2026 financial results, including a net loss of $11.7 million, and provided updates on its clinical progress for SAT-3247 in Duchenne muscular dystrophy (DMD). The company highlighted stable strength and reduced muscle fat in a Phase 2 adult DMD …
Satellos Bioscience (NASDAQ: MSLE) ramps Duchenne R&D and strengthens cash
Satellos Bioscience reported increased net losses in the first half of 2026 due to higher R&D and G&A expenses, driven by advancing its Duchenne muscular dystrophy (DMD) clinical programs, SAT-3247. Despite widening losses, the company significantly strengthened its cash position to $61.8 million through …
Bank Of New York Mellon (BNY) Adds Vikram Malhotra To Its Board
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BNY (NYSE:BNY) has appointed Vikram Malhotra, former Chairman of the Americas at McKinsey & Company, as an independent director to the Board of …
Sharemaestro market context Trend signal active 52 weeks +49.0% · Next-week setup positive 63.3%HelloFresh SE (HLFFF) (Q2 2026) Earnings Call Highlights: Strategic Rebuild Shows Early Promise ...
This article first appeared on GuruFocus. Revenue: Q2 2026 group revenue of EUR1.5 billion, a decline of 7.8% in constant currency. Meal Kit Revenue: Declined 8.9% in constant currency in Q2. Ready-to-Eat Revenue: Declined 8.4% in constant currency in Q2. Other Segment Revenue: Grew …
Sharemaestro market context Price below Trend Line 52 weeks -61.2% · Next-week setup negative 43.1%HelloFresh Q2 Profit Declines
(RTTNews) - HelloFresh SE (HFG.F, HFG.DE) reported second quarter profit of 2.5 million euros compared to 13.3 million euros, prior year. Profit per share was 0.02 euros compared to 0.08 euros. AEBIT excluding impairment was 58.1 million euros compared to 101.4 million euros, last …
Sharemaestro market context Price below Trend Line 52 weeks -61.2% · Next-week setup negative 43.1%Satellogic (SATL) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Founder and Chief Executive Officer - Emiliano Kargieman Chief Financial Officer - Rick Dunn Need a quote from a Motley Fool analyst? Email pr@fool.com Full Conference Call Transcript …
Hello Group (NASDAQ:MOMO) Faces Fresh Pressure After Trend Break
Hello Group (NASDAQ:MOMO), a mobile social networking company, is facing renewed market pressure after its shares dropped below a key long-term moving average. This technical shift highlights concerns about the company's trading momentum, operating outlook, and the divided market sentiment regarding its future performance. …
Assenagon Asset Management S.A. Invests $6.18 Million in Hello Group Inc. Sponsored ADR $MOMO
Assenagon Asset Management S.A. has acquired a new stake of 1,064,894 shares, valued at $6.18 million, in Hello Group Inc. Sponsored ADR (NASDAQ:MOMO). This purchase makes Assenagon one of several institutional investors, including Goldman Sachs and LSV Asset Management, to hold significant positions in …
Hello Group (NASDAQ:MOMO) Stock Crosses Below 200 Day Moving Average - Time to Sell?
Hello Group (NASDAQ:MOMO) shares recently fell below their 200-day moving average, trading at $5.83 against the average of $6.10. Analyst sentiment for the stock is mixed, with some firms issuing Buy ratings and others Hold or Sell, resulting in a MarketBeat consensus of "Hold" …
Satellos Bioscience Inc. (TSX:MSCL) Stock Declines as Biotech Risks and Funding Concerns Pressure Sentiment
Satellos Bioscience Inc. (TSX:MSCL) experienced a 4.52% stock decline due to investor caution surrounding clinical-stage biotechnology companies, which face inherent development and funding risks. The company, focused on regenerative medicine for muscle disorders, is valued based on its clinical progress, technology validation, and potential …
Sharemaestro market context Price above Trend Line 52 weeks +89.0%Hello Group Sets Q2 Results Call After Markets Open Sept. 3
Hello Group (NASDAQ: MOMO) announced it will release its unaudited financial results for the second quarter ended June 30, 2026, before U.S. markets open on Thursday, September 3, 2026. Management will host an earnings conference call on the same day at 7:00 a.m. U.S. …